These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31990964)

  • 1. Is the DSM-5 anxious distress specifier sufficient for measuring anxiety in depressed patients? Implications for measurement-based care.
    Zimmerman M; Kerr S; Balling C; Kiefer R; Dalrymple K
    Ann Clin Psychiatry; 2020 Feb; 32(1):5-11. PubMed ID: 31990964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Walsh E; Rosenstein L
    J Clin Psychiatry; 2014 Jun; 75(6):601-7. PubMed ID: 24813209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of the DSM-5 Anxious Distress Specifier Interview.
    Zimmerman M; Clark H; McGonigal P; Harris L; Holst CG; Martin J
    Compr Psychiatry; 2017 Jul; 76():11-17. PubMed ID: 28384524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of the DSM-5 anxious distress specifier for major depressive disorder.
    Zimmerman M; Martin J; McGonigal P; Harris L; Kerr S; Balling C; Kiefer R; Stanton K; Dalrymple K
    Depress Anxiety; 2019 Jan; 36(1):31-38. PubMed ID: 30311733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring anxiety in depressed patients: A comparison of the Hamilton anxiety rating scale and the DSM-5 Anxious Distress Specifier Interview.
    Zimmerman M; Martin J; Clark H; McGonigal P; Harris L; Holst CG
    J Psychiatr Res; 2017 Oct; 93():59-63. PubMed ID: 28586699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DSM-5 anxious distress specifier in patients with bipolar depression.
    Zimmerman M; Kerr S; Balling C; Kiefer R; Dalrymple K
    Ann Clin Psychiatry; 2020 Aug; 32(3):157-163. PubMed ID: 32343287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is anxious depression? Overlap and agreement between different definitions.
    Zimmerman M; Kerr S; Kiefer R; Balling C; Dalrymple K
    J Psychiatr Res; 2019 Feb; 109():133-138. PubMed ID: 30530208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of a self-report scale for daily assessments of the severity of anxiety symptoms.
    Zimmerman M; Kiefer R; Kerr S; Balling C
    Compr Psychiatry; 2019 Apr; 90():37-42. PubMed ID: 30684831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
    Gaspersz R; Lamers F; Kent JM; Beekman ATF; Smit JH; van Hemert AM; Schoevers RA; Penninx BWJH
    J Psychiatr Res; 2017 Jan; 84():41-48. PubMed ID: 27693981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the DSM-5 Anxious Distress Specifier Interview a valid measure of anxiety in patients with generalized anxiety disorder: A comparison to the Hamilton Anxiety Scale.
    Zimmerman M; Thompson JS; Diehl JM; Balling C; Kiefer R
    Psychiatry Res; 2020 Feb; 286():112859. PubMed ID: 32088508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinically useful anxiety outcome scale.
    Zimmerman M; Chelminski I; Young D; Dalrymple K
    J Clin Psychiatry; 2010 May; 71(5):534-42. PubMed ID: 20361914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between the DSM-5 Anxious Distress Specifier and the Hamilton Depression Rating Scale Anxiety/Somatization Factor.
    Zimmerman M; Clark H; McGonigal P; Harris L; Guzman Holst C; Martin J
    J Nerv Ment Dis; 2018 Feb; 206(2):152-154. PubMed ID: 29373458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability and validity of a self-report scale for daily assessments of the severity of depressive symptoms.
    Zimmerman M; Harris L; Martin J; McGonigal P
    Psychiatry Res; 2018 Dec; 270():581-586. PubMed ID: 30368164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinically useful depression outcome scale.
    Zimmerman M; Chelminski I; McGlinchey JB; Posternak MA
    Compr Psychiatry; 2008; 49(2):131-40. PubMed ID: 18243884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder.
    Gaspersz R; Lamers F; Kent JM; Beekman AT; Smit JH; van Hemert AM; Schoevers RA; Penninx BW
    J Clin Psychiatry; 2017 Feb; 78(2):207-213. PubMed ID: 27035515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the dimensionality of the Hamilton Rating Scale for anxiety and the DSM-5 Anxious-Distress Specifier Interview.
    Rodriguez-Seijas C; Thompson JS; Diehl JM; Zimmerman M
    Psychiatry Res; 2020 Feb; 284():112788. PubMed ID: 31978629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders.
    Jeon SW; Han C; Ko YH; Yoon S; Pae CU; Choi J; Kim JM; Yoon HK; Lee H; Patkar AA; Zimmerman M
    PLoS One; 2017; 12(6):e0179247. PubMed ID: 28604808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How significant is the assessment of the DSM-5 'anxious distress' specifier in patients with major depressive disorder without comorbid anxiety disorders in the continuation/maintenance phase?
    Otsubo T; Hokama C; Sano N; Watanabe Y; Kikuchi T; Tanaka K
    Int J Psychiatry Clin Pract; 2021 Nov; 25(4):385-392. PubMed ID: 33840340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening Anxiety, Irritability, Insomnia, or Panic Predicts Poorer Antidepressant Treatment Outcomes: Clinical Utility and Validation of the Concise Associated Symptom Tracking (CAST) Scale.
    Jha MK; Minhajuddin A; South C; Rush AJ; Trivedi MH
    Int J Neuropsychopharmacol; 2018 Apr; 21(4):325-332. PubMed ID: 29182724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.